This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Crescita Therapeutics, Inc.

Drug Names(s): ibuprofen

Description: IBUFOAM is a topical foam formulation of ibuprofen.

Deal Structure: Nuvo and Crescita
In September 2015, Nuvo Research announced that it plans to split Nuvo into two separate, publicly traded companies. The Reorganization was completed in March 2016. As a result of the Reorganization, the shareholders of what was formerly Nuvo Research now own 100% of Nuvo Pharmaceuticals, a revenue and EBITDA generating commercial healthcare company, and 100% of Crescita Therapeutics, a drug development company.

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug